ArticlePharmacoEconomics - open2024

A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales.

Colin Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.